Strategic report Governance & remuneration Financial statements Investor information 34 Movements in equity Retained earnings and other reserves amounted to 943 million at 31 December 2015 2014 165 million: 2013 3,066 million of which 283 million 2014 337 million: 2013 307 million relates to joint ventures and associated undertakings.
The cumulative translation exchange in equity is as follows: Net translation exchange included in: NonTotal Retained Fair value controlling translation earnings reserve interests exchange m m m m At 1 January 2013 846 8 98 740 Exchange movements on overseas net assets 260 5 35 290 At 31 December 2013 586 3 133 450 Exchange movements on overseas net assets 504 7 16 481 Reclassication of exchange on liquidation or disposal of overseas subsidiaries 219 219 At 31 December 2014 137 4 117 250 Exchange movements on overseas net assets 624 6 8 610 At 31 December 2015 761 10 109 860 The analysis of other comprehensive income by equity category is as follows: NonRetained Other controlling earnings reserves interests Total 2015 m m m m Items that may be subsequently reclassied to income statement: Exchange movements on overseas net assets and net investment hedges 624 6 618 Fair value movements on available-for-sale investments 416 416 Deferred tax on fair value movements on available-for-sale investments 91 91 Reclassication of fair value movements on available-for-sale investments 346 346 Deferred tax on reclassication of fair value movements on available-for-sale investments 36 36 Reclassication of cash ow hedges to income statement 2 2 Fair value movements on cash ow hedges 2 2 Share of other comprehensive income of associates and joint ventures 77 77 Items that will not be reclassied to income statement: Exchange movements on overseas net assets of non-controlling interests 8 8 Remeasurement gains on dened benefit plans 261 261 Deferred tax on remeasurement gains in dened benefit plans 80 80 Other comprehensive expense income for the year 520 25 8 487 NonRetained Other controlling earnings reserves interests Total 2014 m m m m Items that may be subsequently reclassied to income statement: Exchange movements on overseas net assets and net investment hedges 504 7 497 Reclassication of exchange on liquidation or disposal of overseas subsidiaries 219 219 Deferred tax on exchange movements 2 2 Fair value movements on available-for-sale investments 29 29 Deferred tax on fair value movements on available-for-sale investments 78 78 Reclassication of fair value movements on available-for-sale investments 155 155 Deferred tax on reclassication of fair value movements on available-for-sale investments 58 58 Reclassication of cash ow hedges to income statement 5 5 Fair value movements on cash ow hedges 5 5 Deferred tax on fair value movements on cash ow hedges 1 1 Share of other comprehensive income of associates and joint ventures 18 18 Items that will not be reclassied to income statement: Exchange movements on overseas net assets of non-controlling interests 16 16 Remeasurement losses on dened benefit plans 1,181 1,181 Deferred tax on remeasurement losses in dened benefit plans 262 262 Other comprehensive expense income for the year 1,626 140 16 1,750 GSK Annual Report 2015 181 Strategic report Governance & remuneration Financial statements Investor information Notes to the financial statements continued 34 Movements in equity continued NonRetained Other controlling earnings reserves interests Total 2013 m m m m Items that may be subsequently reclassied to income statement: Exchange movements on overseas net assets and net investment hedges 260 5 255 Fair value movements on available-for-sale investments 367 367 Deferred tax on fair value movements on available-for-sale investments 29 29 Reclassication of fair value movements on available-for-sale investments 38 38 Deferred tax on reclassication of fair value movements on available-for-sale investments 7 7 Reclassication of cash ow hedges to income statement 2 2 Fair value movements on cash ow hedges 9 9 Deferred tax on fair value movements on cash ow hedges 1 1 Share of other comprehensive income of associates and joint ventures 15 15 Items that will not be reclassied to income statement: Exchange movements on overseas net assets of non-controlling interests 35 35 Remeasurement gains on dened benefit plans 847 847 Deferred tax on remeasurement gains in dened benefit plans 286 286 Other comprehensive income expense for the year 316 306 35 587 The analysis of other reserves is as follows: ESOP Trust Fair value Cash ow Other shares reserve hedge reserve reserves Total m m m m m At 1 January 2013 391 105 10 2,083 1,787 Transferred to income and expense in the year on disposals 38 2 36 Transferred to income and expense in the year on impairment 1 1 Net fair value movement in the year 347 4 343 Ordinary shares purchased and cancelled 25 25 Ordinary shares acquired by ESOP Trusts 45 45 Write-down of shares held by ESOP Trusts 80 80 At 31 December 2013 356 413 12 2,108 2,153 Transferred to income and expense in the year on disposals 155 5 160 Net fair value movement in the year 16 4 20 Ordinary shares acquired by ESOP Trusts 245 245 Write-down of shares held by ESOP Trusts 450 450 Forward contract on non-controlling interest 21 21 At 31 December 2014 151 274 13 2,129 2,239 Transferred to income and expense in the year on disposals 356 2 354 Transferred to income and expense in the year on impairments 10 10 Net fair value movement in the year 367 2 369 Ordinary shares acquired by ESOP Trusts 99 99 Write-down of shares held by ESOP Trusts 175 175 At 31 December 2015 75 295 9 2,129 2,340 Other reserves include various non-distributable merger and pre-merger reserves amounting to 1,849 million at 31 December 2015 2014 1,849 million: 2013 1,849 million.
Other reserves also include the capital redemption reserve created as a result of the share buy-back programme amounting to 280 million at 31 December 2015 2014 280 million: 2013 280 million.
